Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2014; 20(9): 2403-2411
Published online Mar 7, 2014. doi: 10.3748/wjg.v20.i9.2403
Table 1 Demographics and clinical characteristics of study subjects
Health control (n = 33)CHB (n = 55)ACLF (n = 81)P value
Male 26 (78.79) 46 (83.64) 68 (83.95)0.788
Age (yr)39.73 ± 7.1238.62 ± 12.0842.84 ± 11.120.075
HBV DNA viral load (Log)-6.66 ± 1.495.76 ± 1.730.000
ALT (U/L)18.71 ± 9.33212.07 ± 290.77527.06 ± 790.14< 0.0001
AST (U/L)21.70 ± 11.84109.85 ± 158.32401.72 ± 571.31< 0.0001
Total bilirubin (μmol/L)11.07 ± 3.4728.43 ± 30.72394.98 ± 200.16< 0.0001
Albumin (g/L)46.17 ± 2.0540.02 ± 3.7331.06 ± 3.99< 0.0001
Crea (μmol/L)66.72 ± 16.1472.10 ± 12.6680.96 ± 50.260.1768
International normalized ratio-1.03 ± 0.112.40 ± 1.00< 0.0001
Prothrombin activity-98.86% ± 17.34%31.34% ± 11.24%< 0.0001
White blood cell (× 109/L)5.85 ± 1.225.23 ± 1.308.19 ± 3.79< 0.0001
Platelet (× 1012/L)223.55 ± 22.09170.72 ± 56.45105.90 ± 58.13< 0.0001
Table 2 Clinical features of acute-on-chronic liver failure patients based on different outcomes
FeaturesSpontaneous recovery (n = 33)Non spontaneous recovery (n = 48)P value
Age (yr)41.06 ± 12.4844.06 ± 10.040.235
Male29 (87.88)38 (79.17)0.308
HBV DNA viral load (Log)5.78 ± 1.625.29 ± 2.310.487
ALT (U/L)540.98 ± 555.99525.15 ± 920.580.098
AST (U/L)412.38 ± 525.00397.69 ± 605.020.645
Total bilirubin (μmol/L)371.38 ± 199.37407.99 ± 211.360.435
Albumin (g/L)31.67 ± 3.5830.82 ± 4.240.492
Crea (μmol/L)68.20 ± 31.5988.34 ± 59.380.094
Prothrombin activity35.89% ± 10.62%28.45% ± 10.73%0.003
International normalized ratio2.04 ± 0.492.67 ± 1.180.003
White blood cell (× 109/L)8.40 ± 3.668.20 ± 4.100.571
Platelet (× 1012/L)119.44 ± 51.1795.60 ± 61.650.017
M30 (U/L)891.35 ± 741.27695.24 ± 385.150.663
M65 (U/L)2477.23 ± 1671.102497.77 ± 1503.840.488
M30/M650.38 ± 0.130.32 ± 0.100.032
MELD score23.07 ± 4.8927.59 ± 6.550.002
Child-Pugh score11.42 ± 1.2312.49 ± 1.140.000